Art
J-GLOBAL ID:201802211829766529   Reference number:18A1601542

Phase II trial of biweekly cetuximab and irinotecan as third-line therapy for pretreated KRAS exon 2 wild-type colorectal cancer

前治療を受けたKRASエクソン2野生型結腸直腸癌 に対する3次治療としての隔週投与のセツキシマブとイリノテカンの第II相試験
Author (13):
Material:
Volume: 109  Issue:Page: 2567-2575  Publication year: 2018 
JST Material Number: U0505A  ISSN: 1349-7006  Document type: Article
Article type: 原著論文  Country of issue: United States (USA)  Language: ENGLISH (EN)
Thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
,...
Semi thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
,...
   To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=18A1601542&from=J-GLOBAL&jstjournalNo=U0505A") }}
Author keywords (5):
JST classification (4):
JST classification
Category name(code) classified by JST.
Clinical application of antitumor(=antineoplastic)drugs  ,  Drug therapy(=pharmacotherapy)for tumors  ,  Tumors(=neoplasms)of digestive system  ,  Molecular genetics in general 
Substance index (1):
Substance index
Chemical Substance indexed to the Article.

Return to Previous Page